Your trusted source for GLP-1 research, news, and patient insights.
11 posts in this category
A rejected Medicare GLP-1 Bridge claim is usually a paperwork step, not a denial. See the four reasons and what to ask your pharmacy.
Do you need a rejected claim before the Medicare GLP-1 Bridge prior authorization? What CMS actually says, and how the process really works.
The Medicare GLP-1 Bridge starts July 1, 2026. See who qualifies, which drugs cost $50, and how the prior authorization works step by step.
Lost weight on a GLP-1 and worried a new provider won’t approve? Here is what the FDA labels, the research, and Medicare’s $50 program actually say.
Starting July 1, 2026, Medicare Part D patients could get GLP-1s for $50/month. Here's who qualifies, what's covered, and what's still in motion.
Wegovy and Zepbound coverage is dropping for millions. Learn why GLP-1 prices often jump after you start, and what to do when your costs change.
Medicare covers Wegovy and Zepbound for $50/month starting July 2026. Learn who qualifies, what it costs, and how to prepare for the GLP-1 Bridge.
Prescription approved but insurance said no? Learn your next options for Wegovy, Ozempic, or Zepbound coverage and care.
See how states, Medicare, Medicaid, and employer plans are handling GLP-1 coverage changes in 2026 and what it means for your insurance.
Confused about how Medicare may cover GLP-1 weight loss drugs after the TrumpRx deal Learn who may qualify, expected costs, and key dates until 2027.
Trump’s plan could cut GLP-1 drug prices — like Ozempic® and Wegovy® — to $150/month. Here’s what’s real, what’s pending, and who it helps.
